Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Van Rossum, AGJ"'
Autor:
Oliveira, M, Baird, RD, Voorthuis, RAB, De Boo, L, Van Rossum, AGJ, Cubells, L Garrigos, Munoz, S, Lopez-Garcia, D, Manich, C Saura, Schrier, M, Mandjes, I, Sikorska, K, Schot, M, Kateb, A, Mather, C, Beelen, K, Cortes, J, Caldas, C, Linn, SC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8d77f79c3743194f007a0b0360cfff3e
https://www.repository.cam.ac.uk/handle/1810/350274
https://www.repository.cam.ac.uk/handle/1810/350274
Autor:
Opdam M; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., van Rossum AGJ; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Hoogstraat M; Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Bounova G; Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Horlings HM; Department of Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., van Werkhoven E; Biometrics department, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Mandjes IAM; Data center, The Netherlands Cancer Institute, Amsterdam, the Netherlands., van Leeuwen-Stok AE; Dutch Breast Cancer Research Group, BOOG Study Center, Amsterdam, the Netherlands., Canisius S; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam, the Netherlands., van Tinteren H; Biometrics department, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Imholz ALT; Department of Medical Oncology, Deventer Ziekenhuis, Deventer, the Netherlands., Portielje JEA; Department of Medical Oncology, HagaZiekenhuis, The Hague, the Netherlands.; Department of Medical Oncology, Leiden University Medical Center, Leiden, the Netherlands., Bos MEMM; Department of Internal Oncology, Reinier de Graaf Gasthuis, Delft, the Netherlands., Bakker S; Department of Medical Oncology, Zaans Medisch Centrum, Zaandam, the Netherlands., Wesseling J; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Department of Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Department of Pathology, Leiden University Medical Center, Leiden, the Netherlands., Kester L; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute, The Netherlands Cancer Institute, Amsterdam, the Netherlands., van Rheenen J; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Rutgers EJ; Department of Surgical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., de Menezes RX; Biostatistics Centre, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Department of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Wessels LFA; Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Faculty of Electrical Engineering, Mathematics and Computer Science, Delft University of Technology, Delft, the Netherlands., Kok M; Division of Tumor biology & Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Oosterkamp HM; Department of Medical Oncology, Haaglanden Medisch Centrum, The Hague, the Netherlands., Linn SC; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Department of Pathology, University Medical Center, Utrecht, the Netherlands.
Publikováno v:
IScience [iScience] 2024 Jun 29; Vol. 27 (8), pp. 110425. Date of Electronic Publication: 2024 Jun 29 (Print Publication: 2024).
Autor:
Vliek SB; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Noordhoek I; Department of Medical Oncology, Leiden University Medical Center, Leiden, the Netherlands.; Department of Surgery, Leiden University Medical Center, Leiden, the Netherlands., Meershoek-Klein Kranenbarg E; Department of Surgery, Leiden University Medical Center, Leiden, the Netherlands., van Rossum AGJ; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Dezentje VO; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Jager A; Dutch Breast Cancer Research Group, Amsterdam, the Netherlands., Hokken JWE; Department of Medical Oncology, Groene Hart Ziekenhuis, Gouda, the Netherlands., Putter H; Department of Medical Statistics, Leiden University Medical Center, Leiden, the Netherlands., van der Velden AWG; Department of Internal Medicine, Martini Hospital, Groningen, the Netherlands., Hendriks MP; Department of Medical Oncology, Northwest Clinics, Alkmaar, the Netherlands., Bakker SD; Department of Internal Medicine, Zaans Medical Centre, Zaandam, the Netherlands., van Riet YEA; Department of Surgical Oncology, Catharina Hospital, Eindhoven, the Netherlands., Tjan-Heijnen VCG; Department of Medical Oncology, Maastricht University Medical Center, Maastricht, the Netherlands., Portielje JEA; Department of Medical Oncology, Leiden University Medical Center, Leiden, the Netherlands., Kroep JR; Department of Medical Oncology, Leiden University Medical Center, Leiden, the Netherlands., Nortier JWR; Department of Medical Oncology, Leiden University Medical Center, Leiden, the Netherlands., van de Velde CJH; Department of Surgery, Leiden University Medical Center, Leiden, the Netherlands., Linn SC; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Department of Pathology, University Medical Center Utrecht, Utrecht, the Netherlands.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2022 Sep 01; Vol. 40 (25), pp. 2934-2945. Date of Electronic Publication: 2022 Apr 20.
Autor:
Kester L; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute-The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute-Hubrecht Institute- KNAW & University Medical Centre Utrecht, Utrecht, the Netherlands., Seinstra D; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute-The Netherlands Cancer Institute, Amsterdam, the Netherlands., van Rossum AGJ; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Vennin C; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute-The Netherlands Cancer Institute, Amsterdam, the Netherlands., Hoogstraat M; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute-The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam, the Netherlands., van der Velden D; Division of Molecular Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Opdam M; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., van Werkhoven E; Department of Biometrics, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Hahn K; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute-The Netherlands Cancer Institute, Amsterdam, the Netherlands., Nederlof I; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Lips EH; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Mandjes IAM; Data Center, The Netherlands Cancer Institute, Amsterdam, the Netherlands., van Leeuwen-Stok AE; Dutch Breast Cancer Research Group, BOOG Study Center, Amsterdam, the Netherlands., Canisius S; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Division of Molecular Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., van Tinteren H; Department of Biometrics, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Imholz ALT; Department of Medical Oncology, Deventer Ziekenhuis, Deventer, the Netherlands., Portielje JEA; Department of Medical Oncology, HagaZiekenhuis, The Hague, the Netherlands.; Department of Medical Oncology, Leiden University Medical Center, Leiden, the Netherlands., Bos MEMM; Department of Internal Oncology, Reinier de Graaf Gasthuis, Delft, the Netherlands., Bakker SD; Department of Medical Oncology, Zaans Medisch Centrum, Zaandam, the Netherlands., Rutgers EJ; Department of Surgical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Horlings HM; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Division of Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Wesseling J; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Division of Diagnostic Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Voest EE; Oncode Institute-The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Division of Molecular Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Wessels LFA; Oncode Institute-The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Division of Molecular Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Kok M; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Division of Tumor Biology & Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Oosterkamp HM; Department of Medical Oncology, Haaglanden Medisch Centrum, Den Haag, the Netherlands., van Oudenaarden A; Oncode Institute-Hubrecht Institute- KNAW & University Medical Centre Utrecht, Utrecht, the Netherlands., Linn SC; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Department of Pathology, University Medical Center, Utrecht, the Netherlands., van Rheenen J; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute-The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Molecular Cancer Research, Center Molecular Medicine, University Medical Center Utrecht, Utrecht, the Netherlands.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2022 Mar 01; Vol. 28 (5), pp. 960-971.
Autor:
van Rossum AGJ; Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands., Mandjes IAM; Data Center, Netherlands Cancer Institute, Amsterdam, The Netherlands., van Werkhoven E; Biometrics Department, Netherlands Cancer Institute, Amsterdam, The Netherlands., van Tinteren H; Biometrics Department, Netherlands Cancer Institute, Amsterdam, The Netherlands., van Leeuwen-Stok AE; Dutch Breast Cancer Research Group, BOOG Study Center, Amsterdam, The Netherlands., Nederlof P; Department of Molecular Diagnostics, Netherlands Cancer Institute, Amsterdam, The Netherlands., Portielje JEA; Department of Medical Oncology, HagaZiekenhuis, The Hague, The Netherlands.; Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands., van Alphen RJ; Department of Medical Oncology, Elisabeth-TweeSteden Hospital, Tilburg, The Netherlands., Platte E; Clinical Chemical Laboratory, Netherlands Cancer Institute, Amsterdam, The Netherlands., van den Broek D; Clinical Chemical Laboratory, Netherlands Cancer Institute, Amsterdam, The Netherlands., Huitema A; Pharmacy, Netherlands Cancer Institute, Amsterdam, The Netherlands., Kok M; Division of Molecular Oncology and Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands., Linn SC; Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Pathology, University Medical Center, Utrecht, The Netherlands., Oosterkamp HM; Department of Medical Oncology, Haaglanden Medisch Centrum, The Hague, The Netherlands.
Publikováno v:
Breast care (Basel, Switzerland) [Breast Care (Basel)] 2021 Dec; Vol. 16 (6), pp. 598-606. Date of Electronic Publication: 2021 Jan 22.
Autor:
Baird RD; Cancer Research UK Cambridge Centre, Cambridge, United Kingdom. rdb39@cam.ac.uk., van Rossum AGJ; Netherlands Cancer Institute, Amsterdam, the Netherlands., Oliveira M; Vall d'Hebron University Hospital and Institute of Oncology, Barcelona, Spain., Beelen K; Netherlands Cancer Institute, Amsterdam, the Netherlands.; Reinier de Graaf Gasthuis, Delft, the Netherlands., Gao M; Cancer Research UK Cambridge Centre, Cambridge, United Kingdom., Schrier M; Netherlands Cancer Institute, Amsterdam, the Netherlands., Mandjes IAM; Netherlands Cancer Institute, Amsterdam, the Netherlands., Garcia-Corbacho J; Cancer Research UK Cambridge Centre, Cambridge, United Kingdom., Vallier AL; Cancer Research UK Cambridge Centre, Cambridge, United Kingdom., Dougall G; Cancer Research UK Cambridge Centre, Cambridge, United Kingdom., van Werkhoven E; Netherlands Cancer Institute, Amsterdam, the Netherlands., Linossi C; Cancer Research UK Cambridge Centre, Cambridge, United Kingdom., Kumar S; Cancer Research UK Cambridge Centre, Cambridge, United Kingdom., van Tinteren H; Netherlands Cancer Institute, Amsterdam, the Netherlands., Callari M; Cancer Research UK Cambridge Centre, Cambridge, United Kingdom., Beddowes E; Cancer Research UK Cambridge Centre, Cambridge, United Kingdom., Perez-Garcia JM; Vall d'Hebron University Hospital and Institute of Oncology, Barcelona, Spain.; Ramon y Cajal University Hospital, Madrid, Spain., Rosing H; Netherlands Cancer Institute, Amsterdam, the Netherlands., Platte E; Netherlands Cancer Institute, Amsterdam, the Netherlands., Nederlof P; Netherlands Cancer Institute, Amsterdam, the Netherlands., Schot M; Netherlands Cancer Institute, Amsterdam, the Netherlands., de Vries Schultink A; Netherlands Cancer Institute, Amsterdam, the Netherlands., Bernards R; Netherlands Cancer Institute, Amsterdam, the Netherlands., Saura C; Vall d'Hebron University Hospital and Institute of Oncology, Barcelona, Spain., Gallagher W; University College Dublin, Dublin, Ireland., Cortès J; Vall d'Hebron University Hospital and Institute of Oncology, Barcelona, Spain.; Ramon y Cajal University Hospital, Madrid, Spain., Caldas C; Cancer Research UK Cambridge Centre, Cambridge, United Kingdom., Linn SC; Netherlands Cancer Institute, Amsterdam, the Netherlands.; University Medical Center Utrecht, Utrecht, the Netherlands.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2019 Nov 15; Vol. 25 (22), pp. 6598-6605. Date of Electronic Publication: 2019 Aug 22.
Autor:
van Rossum AGJ; Department of Molecular Pathology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands., Kok M; Department of Medical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands., van Werkhoven E; Biometrics Department, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands., Opdam M; Department of Molecular Pathology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands., Mandjes IAM; Data Centre, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands., van Leeuwen-Stok AE; Dutch Breast Cancer Research Group, BOOG Study Centre, IJsbaanpad 9-11, 1076 CV, Amsterdam, The Netherlands., van Tinteren H; Biometrics Department, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands., Imholz ALT; Department of Medical Oncology, Deventer Ziekenhuis, Nico Bolkesteinlaan 75, 7416 SE, Deventer, The Netherlands., Portielje JEA; Department of Medical Oncology, HagaZiekenhuis, Els Borst-Eilersplein 275, 2545 AA, The Hague, The Netherlands., Bos MMEM; Department of Internal Oncology, Reinier de Graaf Gasthuis, Reinier de Graafweg 5, 2625 AD, Delft, The Netherlands., van Bochove A; Department of Medical Oncology, Zaans Medisch Centrum, Koningin Julianaplein 58, 1502 DV, Zaandam, The Netherlands., Wesseling J; Department of Molecular Pathology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands; Department of Pathology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands., Rutgers EJ; Department of Surgical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands., Linn SC; Department of Molecular Pathology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands; Department of Medical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands; Department of Pathology, University Medical Centre, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands. Electronic address: s.linn@nki.nl., Oosterkamp HM; Department of Medical Oncology, Haaglanden Medisch Centrum, The Hague, The Netherlands.
Publikováno v:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2018 Oct; Vol. 102, pp. 40-48.
Autor:
van Rossum AGJ; Netherlands Cancer Institute, Amsterdam, The Netherlands., Schouten PC; Netherlands Cancer Institute, Amsterdam, The Netherlands., Weber KE; German Breast Group, Neu-Isenburg, Germany., Nekljudova V; German Breast Group, Neu-Isenburg, Germany., Denkert C; Charité - Universitätsmedizin, Berlin, Germany., Solbach C; University Women's Hospital, Frankfurt, Germany., Köhne CH; University Clinic for Internal Medicine Oncology and Hematology, Oldenburg, Germany., Thomssen C; University Halle Wittenberg, Halle, Germany., Forstbauer H; Gesellschaft für onkologische Studien, Troisdorf, Germany., Hoffmann G; St. Josefs-Hospital, Wiesbaden, Germany., Kohls A; Ev. Krankenhaus, Ludwigsfelde-Teltow, Germany., Schmatloch S; Elisabeth Krankenhaus, Kassel, Germany., Schem C; Women's Hospital, University of Kiel, Kiel, Germany., von Minckwitz G; German Breast Group, Neu-Isenburg, Germany., Karn T; University Women's Hospital, Frankfurt, Germany., Möbus VJ; University Women's Hospital, Frankfurt, Germany., Linn SC; Netherlands Cancer Institute, Amsterdam, The Netherlands.; University Medical Center, Utrecht, The Netherlands., Loibl S; German Breast Group, Neu-Isenburg, Germany., Marmé F; Center for Gynecological Oncology at University Women's Hospital, Im Neuenheimer Feld 460, 69120, Heidelberg, Germany. frederikmarme@me.com.
Publikováno v:
Breast cancer research and treatment [Breast Cancer Res Treat] 2017 Dec; Vol. 166 (3), pp. 775-785. Date of Electronic Publication: 2017 Aug 18.
Autor:
van Rossum AGJ; Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands., Kok M; Division of Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands., McCool D; Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands., Opdam M; Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands., Miltenburg NC; Department of Neurology, Medical Center Slotervaart, Amsterdam, The Netherlands., Mandjes IAM; Data Center, Netherlands Cancer Institute, Amsterdam, The Netherlands., van Leeuwen-Stok E; Dutch Breast Cancer Research Group, BOOG Study Center, Amsterdam, The Netherlands., Imholz ALT; Department of Medical Oncology, Deventer Ziekenhuis, Deventer, The Netherlands., Portielje JEA; Department of Medical Oncology, HagaZiekenhuis, The Hague, The Netherlands., Bos MMEM; Department of Medical Oncology, Reinier de Graaf Groep, Delft, The Netherlands., van Bochove A; Department of Medical Oncology, Zaans Medisch Centrum, Zaandam, The Netherlands., van Werkhoven E; Biometrics Division, Netherlands Cancer Institute, Amsterdam, The Netherlands., Schmidt MK; Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands., Oosterkamp HM; Department of Medical Oncology, Haaglanden Medisch Centrum, The Hague, The Netherlands., Linn SC; Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Pathology, University Medical Center, Utrecht, The Netherlands.
Publikováno v:
Oncotarget [Oncotarget] 2017 Nov 27; Vol. 8 (69), pp. 113531-113542. Date of Electronic Publication: 2017 Nov 27 (Print Publication: 2017).